- The FDA approves generic versions of Novartis' (NVS +0.2%) MS med Gilenya (fingolimod) made by HEC Pharm Co., Ltd., Biocon Limited and Sun Pharmaceutical Industries Limited.
- The sphingosine 1-phosphate receptor modulator accounted for almost 7% of the company's Q3 revenues of $12,172M and over 11% of its Innovative Medicine sales of $7,286M.